What is a papilloma of the esophagus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Papilloma of the Esophagus?

An esophageal squamous papilloma is a rare benign tumor of the esophagus, typically appearing as a small, exophytic growth with papillary projections, often detected incidentally during endoscopy, and is presumed to be associated with human papillomavirus (HPV) infection in approximately 46-50% of cases. 1, 2

Clinical Characteristics

Epidemiology and Presentation:

  • Esophageal squamous papillomas occur in approximately 0.26-0.35% of patients undergoing upper endoscopy 1, 3
  • The lesions affect both sexes relatively equally, with a mean age of presentation around 45 years 1
  • Most papillomas (approximately 90%) are solitary lesions, though multifocal presentations occur in a minority of cases 1
  • The vast majority are asymptomatic and discovered incidentally during esophagogastroduodenoscopy performed for other indications 4, 5
  • Larger papillomas may rarely cause dysphagia, odynophagia, or bleeding 4

Anatomic Distribution:

  • Papillomas are most commonly located in the middle and upper portions of the intrathoracic esophagus 1
  • This distinct localization differs from reflux esophagitis (which affects the lower esophagus), suggesting that papillomas are not caused by hiatus hernia or gastroesophageal reflux 1

Endoscopic and Histologic Features

Macroscopic Appearance:

  • Papillomas appear as exophytic, sessile, or pedunculated growths with papillary projections 2
  • They can appear pink or white depending on the degree of keratinization 2
  • Most lesions are only a few millimeters in size, though larger lesions (up to 8 mm) have been reported 4

Microscopic Features:

  • Histologically characterized by squamous epithelium with papillary architecture and fibrovascular cores 2
  • May demonstrate koilocytes (cells with perinuclear halos), which are suggestive of HPV infection 2

HPV Association and Oncogenic Potential

Viral Etiology:

  • HPV DNA can be detected in approximately 46-50% of esophageal papillomas using PCR techniques 1, 2
  • When HPV is detected, high-risk oncogenic genotypes (particularly HPV 16 and 18) predominate 1
  • Low-risk HPV genotypes 6 and 11 are also commonly detected 2

Malignant Transformation Risk:

  • The malignant potential of esophageal papillomas remains controversial and appears to be very low 1, 3, 6
  • Direct transformation of papilloma to carcinoma has not been definitively documented in most series 1
  • Synchronous esophageal squamous cell carcinoma occurs rarely (approximately 1.3% in one large series) 1
  • Papillomas harboring high-risk HPV genotypes may carry increased risk for dysplasia, particularly in immunosuppressed individuals 2, 7
  • The identical anatomic localization of papillomas and squamous cell carcinoma in the esophagus suggests potentially shared etiology (HPV infection), though causality remains unproven 1

Important Caveat: Unlike anogenital condylomata (where dysplasia and malignant transformation are well-documented), esophageal papillomas appear to behave in a more benign fashion 3, 6

Management Approach

Diagnostic Workup:

  • Complete endoscopic removal with histological examination is recommended for definitive diagnosis and to exclude dysplasia or malignancy 7, 5, 6
  • Small papillomas (few millimeters) can be removed with standard biopsy forceps 1, 4
  • Larger lesions require endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) techniques 1, 4
  • HPV testing via PCR should be considered, particularly for multifocal lesions or in immunosuppressed patients 1, 6

Treatment Strategy:

  • Surgical excision (endoscopic resection) is the standard of care to ensure complete removal of infected epithelium at the base and to rule out dysplasia 2, 7
  • Complete excision minimizes recurrence risk, which is uncommon (reported in <1% of cases when completely removed) 1, 4
  • Incomplete removal may lead to recurrence due to residual infected epithelium 2

Surveillance Recommendations:

  • For small, solitary, non-dysplastic papillomas that are completely excised, routine long-term surveillance may not be necessary 6
  • Multifocal lesions, high-risk HPV-positive cases, or lesions in immunosuppressed patients warrant closer endoscopic follow-up 6, 7
  • Follow-up endoscopy at 6-12 months is reasonable for higher-risk presentations to assess for recurrence 4, 6
  • No standardized surveillance protocol currently exists, and practice varies by institution 6

Differential Diagnosis

Key Distinctions:

  • Must be differentiated from verrucous carcinoma (carcinoma verrucosum), which can have similar papillary architecture but demonstrates invasive features 1
  • Condyloma acuminatum can appear similar but typically occurs in younger patients and is more commonly associated with sexual transmission 2
  • Verruca vulgaris is uncommon in the esophagus and typically shows prominent hyperkeratosis 2

Clinical Pitfalls

  • Do not assume all papillary esophageal lesions are benign—histological confirmation is mandatory 5
  • Incomplete excision may lead to recurrence, so ensure removal includes the base of the lesion 2
  • In immunosuppressed patients, maintain higher suspicion for dysplasia and consider more aggressive surveillance 2, 7
  • The presence of high-risk HPV does not definitively predict malignant transformation, but warrants closer monitoring 1, 6

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.